01 November 2018
Visiongain has launched a new pharma report: Global Genomics Market Report : Sequencing, Microarray, PCR, Nucleic Acid Extraction and Purification, Diagnostic Test, Genetic Test, Newborn Screening, Preimplantation Testing, Prenatal Testing, Carrier Testing, Molecular Test, Chromosomal Test, Biochemical Test, Diagnostic, Drug Discovery, Precision Medicine, Research Centers, Hospitals and Clinics, Pharmaceutical Companies and Others.
Genome-based research is already empowering medical researchers to develop improved diagnostics, more effective therapeutic strategies, evidence-based approaches for demonstrating clinical efficacy, and better decision-making tools for patients and providers. The genomics market has been segmented based on technology, test type, method, application, end-user, and geography.
The lead analyst of the report commented "Genomics market is quite fragmented. Companies are investing in research and development activities and the industry growth is highly positive. There is a strong and established customer base for genomics market which is continually progressing. The products are very much undifferentiated as the technological arena is limited to certain extents and, each application segment is demanding technological advancement.
With increasing demand for diagnostic and precision medicines, market players are introducing product developments to differentiate themselves with the best and cost-effective solutions to the market. There is a presence of many domestic and global level players with intense competition among each other."
Leading companies featured in the report include Agilent Technologies, Inc., Danaher Corporation, Eppendorf AG, BGI Genomics Co. Ltd., Eurofins Scientific, GE Healthcare Life Sciences, Illumina, Inc., Oxford Nanopore Technologies Ltd., Qiagen NV, Roche, Thermo Fisher Scientific, Inc.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 207 336 6100
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
Some of the major factors fuelling the growth of global market include significant advantages associated with PIM solutions and inclination towards centralized models among across pharma sector.
19 October 2020
The coronavirus outbreak has negatively impacted all the economies and industries across the globe. Hence, for the next 1-2 years, the global respiratory drug delivery market is expected to take a hit.
12 October 2020
We predict strong revenue growth through to 2030. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
02 October 2020
The development of mRNA vaccines is driven by new biotechnologies and nanotechnologies. Emerging delivery technologies, such as electroporation (EP), innovative vaccine formats like mRNA preventive boost, and new molecular adjuvant technologies are particularly important for mRNA vaccines reaching their potential.